Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W4382918529', 'doi': 'https://doi.org/10.3760/cma.j.cn112138-20220630-00488', 'title': '[Research progress of arginine vasopressin V2 receptor antagonist tolvaptan in the treatment of cirrhotic ascites].', 'display_name': '[Research progress of arginine vasopressin V2 receptor antagonist tolvaptan in the treatment of cirrhotic ascites].', 'publication_year': 2023, 'publication_date': '2023-07-01', 'ids': {'openalex': 'https://openalex.org/W4382918529', 'doi': 'https://doi.org/10.3760/cma.j.cn112138-20220630-00488', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/37394862'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/37394862', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5082799922', 'display_name': 'Yufeng Hu', 'orcid': 'https://orcid.org/0000-0002-9416-262X'}, 'institutions': [{'id': 'https://openalex.org/I4210088328', 'display_name': 'Third Hospital of Hebei Medical University', 'ror': 'https://ror.org/004eknx63', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210088328']}, {'id': 'https://openalex.org/I111381250', 'display_name': 'Hebei Medical University', 'ror': 'https://ror.org/04eymdx19', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I111381250']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Y Y Hu', 'raw_affiliation_strings': ['Department of Infectious Diseases, the Third Affiliated Hospital of Hebei Medical University, Shijiazhuang 050051, China.'], 'affiliations': [{'raw_affiliation_string': 'Department of Infectious Diseases, the Third Affiliated Hospital of Hebei Medical University, Shijiazhuang 050051, China.', 'institution_ids': ['https://openalex.org/I4210088328', 'https://openalex.org/I111381250']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100368911', 'display_name': 'Xiang Zhang', 'orcid': 'https://orcid.org/0000-0003-1003-9892'}, 'institutions': [{'id': 'https://openalex.org/I4210088328', 'display_name': 'Third Hospital of Hebei Medical University', 'ror': 'https://ror.org/004eknx63', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210088328']}, {'id': 'https://openalex.org/I111381250', 'display_name': 'Hebei Medical University', 'ror': 'https://ror.org/04eymdx19', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I111381250']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'X Zhang', 'raw_affiliation_strings': ['Department of Infectious Diseases, the Third Affiliated Hospital of Hebei Medical University, Shijiazhuang 050051, China.'], 'affiliations': [{'raw_affiliation_string': 'Department of Infectious Diseases, the Third Affiliated Hospital of Hebei Medical University, Shijiazhuang 050051, China.', 'institution_ids': ['https://openalex.org/I4210088328', 'https://openalex.org/I111381250']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5015514821', 'display_name': 'Y D Wang', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210088328', 'display_name': 'Third Hospital of Hebei Medical University', 'ror': 'https://ror.org/004eknx63', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210088328']}, {'id': 'https://openalex.org/I111381250', 'display_name': 'Hebei Medical University', 'ror': 'https://ror.org/04eymdx19', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I111381250']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Y D Wang', 'raw_affiliation_strings': ['Department of Infectious Diseases, the Third Affiliated Hospital of Hebei Medical University, Shijiazhuang 050051, China.'], 'affiliations': [{'raw_affiliation_string': 'Department of Infectious Diseases, the Third Affiliated Hospital of Hebei Medical University, Shijiazhuang 050051, China.', 'institution_ids': ['https://openalex.org/I4210088328', 'https://openalex.org/I111381250']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5103119164', 'display_name': 'Caiyan Zhao', 'orcid': 'https://orcid.org/0000-0001-5997-4641'}, 'institutions': [{'id': 'https://openalex.org/I4210088328', 'display_name': 'Third Hospital of Hebei Medical University', 'ror': 'https://ror.org/004eknx63', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210088328']}, {'id': 'https://openalex.org/I111381250', 'display_name': 'Hebei Medical University', 'ror': 'https://ror.org/04eymdx19', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I111381250']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'C Y Zhao', 'raw_affiliation_strings': ['Department of Infectious Diseases, the Third Affiliated Hospital of Hebei Medical University, Shijiazhuang 050051, China.'], 'affiliations': [{'raw_affiliation_string': 'Department of Infectious Diseases, the Third Affiliated Hospital of Hebei Medical University, Shijiazhuang 050051, China.', 'institution_ids': ['https://openalex.org/I4210088328', 'https://openalex.org/I111381250']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 71}, 'biblio': {'volume': '62', 'issue': '7', 'first_page': '881', 'last_page': '884'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12963', 'display_name': 'Neurotoxic Effects of Anesthetic Agents on Brain Development', 'score': 0.9432, 'subfield': {'id': 'https://openalex.org/subfields/2806', 'display_name': 'Developmental Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12963', 'display_name': 'Neurotoxic Effects of Anesthetic Agents on Brain Development', 'score': 0.9432, 'subfield': {'id': 'https://openalex.org/subfields/2806', 'display_name': 'Developmental Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11967', 'display_name': 'Diagnosis and Management of Hyponatremia', 'score': 0.9339, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/tolvaptan', 'display_name': 'Tolvaptan', 'score': 0.97303}, {'id': 'https://openalex.org/keywords/treatment', 'display_name': 'Treatment', 'score': 0.517592}, {'id': 'https://openalex.org/keywords/vasopressin-antagonists', 'display_name': 'Vasopressin Antagonists', 'score': 0.5032875}], 'concepts': [{'id': 'https://openalex.org/C2780615674', 'wikidata': 'https://www.wikidata.org/wiki/Q426132', 'display_name': 'Tolvaptan', 'level': 3, 'score': 0.97303}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.94943106}, {'id': 'https://openalex.org/C2780496750', 'wikidata': 'https://www.wikidata.org/wiki/Q193889', 'display_name': 'Ascites', 'level': 2, 'score': 0.78626466}, {'id': 'https://openalex.org/C2776370428', 'wikidata': 'https://www.wikidata.org/wiki/Q21124841', 'display_name': 'Vasopressin', 'level': 2, 'score': 0.775367}, {'id': 'https://openalex.org/C20352681', 'wikidata': 'https://www.wikidata.org/wiki/Q14890035', 'display_name': 'Arginine vasopressin receptor 2', 'level': 4, 'score': 0.6884885}, {'id': 'https://openalex.org/C2777468819', 'wikidata': 'https://www.wikidata.org/wiki/Q173670', 'display_name': 'Arginine', 'level': 3, 'score': 0.6865213}, {'id': 'https://openalex.org/C90474776', 'wikidata': 'https://www.wikidata.org/wiki/Q24784390', 'display_name': 'Vasopressin receptor', 'level': 4, 'score': 0.6559374}, {'id': 'https://openalex.org/C2776885963', 'wikidata': 'https://www.wikidata.org/wiki/Q245204', 'display_name': 'Antagonist', 'level': 3, 'score': 0.60330844}, {'id': 'https://openalex.org/C2779881253', 'wikidata': 'https://www.wikidata.org/wiki/Q1587028', 'display_name': 'Vasopressin Antagonists', 'level': 4, 'score': 0.5032875}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.48732886}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.44113925}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.4245378}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.34185925}, {'id': 'https://openalex.org/C515207424', 'wikidata': 'https://www.wikidata.org/wiki/Q8066', 'display_name': 'Amino acid', 'level': 2, 'score': 0.1127384}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.09068638}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D001201', 'descriptor_name': 'Ascites', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D017483', 'descriptor_name': 'Receptors, Vasopressin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D001201', 'descriptor_name': 'Ascites', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008103', 'descriptor_name': 'Liver Cirrhosis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008103', 'descriptor_name': 'Liver Cirrhosis', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D008103', 'descriptor_name': 'Liver Cirrhosis', 'qualifier_ui': 'Q000150', 'qualifier_name': 'complications', 'is_major_topic': False}, {'descriptor_ui': 'D012964', 'descriptor_name': 'Sodium', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077602', 'descriptor_name': 'Tolvaptan', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077602', 'descriptor_name': 'Tolvaptan', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/37394862', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4382918529', 'https://openalex.org/W2468759776', 'https://openalex.org/W2387992182', 'https://openalex.org/W2334670702', 'https://openalex.org/W2138491398', 'https://openalex.org/W2078955502', 'https://openalex.org/W2053805783', 'https://openalex.org/W2034225154', 'https://openalex.org/W2023222534', 'https://openalex.org/W1996846474'], 'abstract_inverted_index': {'腹水是肝硬化常见且增加死亡风险的重要并发症之一。精氨酸加压素(AVP)V2受体拮抗剂托伐普坦(TLV)作为肝硬化腹水治疗的新型药物选择,尤其适合合并低钠血症患者,其作用疗效及安全性评价在多项研究中确立。但也有最新证据显示肝硬化合并难治性腹水患者使用TLV获益有限。本文将对TLV治疗肝硬化合并腹水的作用机制、疗效与安全性及应用策略进行综述,以期规范其在肝硬化合并腹水患者中的合理应用。.': [0]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4382918529', 'counts_by_year': [], 'updated_date': '2024-09-19T17:16:41.389565', 'created_date': '2023-07-04'}